Abstract: A method of securing a patient onto an operating table when the patient is in a position such as the trendelenburg position and apparatus therefor including a kit. A viscoelastic pad is used to support and hold a patient on a medical procedure table during a medical procedure performed while the table, and thus the patient lying thereon, is in an inclined position, such as the Trendelenburg position. The viscoelastic pad has characteristics which promote a minimization of pressure forces on the patient's body, as well as promote a secure cushioning and holding of the patient in a desired position on the table, in order to minimize injury to the patient.

Abstract: Exemplary head stabilization devices or head fixation devices (HFDs) include a central head support for supporting a patient's head from beneath. The HFDs are connectable to a patient support device such as an operating table. The HFDs can include a cushion associated with the central head support or base assembly and pads extending from adjustable extension bars that provide lateral support. The cushion and/or pads comprise a fluid chamber and a shape-conforming material chamber. The chambers work together such that the cushion and/or pads conform to the patient's head and can be adjusted in position and pressure to provide stabilization to the patient's head. In some instances, the cushions and pads used with the HFDs can include multiple chambers that permit pressure control by way of controlling a fluid volume within specific chambers.

Abstract: An apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is described where one embodiment may comprise a motor configured to be in vibrational conductance with an area of the subject, one or more sensors in communication with the motor for receiving feedback relating to the vibrational conductance, and a controller in communication with the motor. The controller may be configured to receive the feedback through the one or more sensors and determine an amount of vibrational conductance transmitted to the area of the subject such that the feedback is correlated to a fit of the motor relative to the area of the subject. Additionally, the controller may be further configured to adjust one or more parameters of the motor in response to the correlated fit until the feedback is optimized within a predetermined range for treatment.

Abstract: An exercise apparatus comprises a platform that is configured to support a user thereon. The apparatus also comprises at least first and second oscillation mechanisms that are arranged to cause movement of the platform. The first oscillation mechanism is arranged to impart drive to the platform to oscillate in a first frequency range and at a first amplitude. The second oscillation mechanism is arranged to impart drive to the platform to oscillate in a second frequency range and at a second amplitude. The first amplitude can be greater than the second amplitude. Further, each of the first and second oscillation mechanisms can be arranged to generally impart drive to the platform in substantially the same direction. The first and second mechanisms may operate through a drive element that combines drive imparted from the first and second oscillation mechanisms to cause the movement of the platform.

Abstract: A lift system has a back panel and a seat panel to provide a seat for a user. The back panel is slidably mounted on a support column via slider so that the back panel can be moved up and down to adjust the seat height. The seat panel can be flipped back to accommodate a user in a standing posture when the back panel is in an upright position. The back panel, together with the support column, can be oriented in a horizontal position and the seat panel can be adjusted similarly to support a user in a lying posture. With the support column, the lift system can be attached to a wheeled frame for mobility, but it can also be attached to a pole, a rotatable arm, a wall or a ceiling depending on the need of the user.

Abstract: A massage mechanism and its massager. The massage mechanism includes a base, motor, drive assembly, first drive shaft, first bearing, first massage drive assembly, first massage head assembly, inter-shaft drive assembly, second transmission shaft, second bearing, second massage drive assembly and second massage head. There is also provided a massager including the foregoing massage mechanism. The mechanism could optimize those unstable and noisy features for an ideal massage experience, and solve the problem that multiple massage actions cannot be driven by a single motor.

Abstract: The movement inducing device includes a plurality of air bags, each being provided with a contacting portion configured to contact with a user and induce a movement of an intended skeletal muscle of the user; a drive mechanism configured to expand and compress the air bags by adjusting supply and discharge of air to and from each air bag and a control unit provided with a drive control unit configured to control driving of the drive mechanism to make the intended skeletal muscle of the user perform at least one of an isotonic muscle activity, an isometric muscle activity and an isokinetic muscle activity.

Abstract: A portable foam roller and sitting pad system including a bottle having a generally cylindrical body, and a flexible foam pad configured to be secured around the bottle creating a therapeutic foam rolling device. The flexible foam pad further provides a sitting pad for a user when unsecured from the bottle.

Abstract: A device for sexual stimulation of the human body, the device including a phallus-shaped stimulation body. The thickness and/or the length of the stimulation body is variable in regions. The stimulation body has a preferably exchangeable stimulation element to permit the regional variation of the thickness, and the stimulation element is movable in the direction of the longitudinal axis of the stimulation body and/or in the circumferential direction of the stimulation body. The stimulation element expediently has at least one magnetic holding device, preferably a permanent magnet, and at least one magnetic carrier for the stimulation element is arranged movably inside the stimulation body.

Abstract: In embodiments, a CPR chest compression system includes a retention structure that can retain the patient's body, and a compression mechanism that can perform automatically CPR compressions and releases to the patient's chest. The compression mechanism can pause the performing of the CPR compressions for a short time, so that an attendant can check the patient. The CPR system can include a user interface that can output a human-perceptible check patient prompt, to alert an attendant to check the patient during the pause. The compression mechanism can during a CPR session retreat a distance away from the patient's chest whereby the patient's chest can expand without active decompression of the patient's chest beyond the chest's natural resting position.

Abstract: A system for providing cardiopulmonary resuscitation (CPR) feedback configurable at a point of use is described that includes one or more sensors configured to generate a signal corresponding to motion of the chest during an administration of chest compressions and a defibrillator configured to couple to the one or more sensors, the defibrillator including an input device configured to accept user input indicative of a compression depth goal, one or more processors and a memory, the one or more processors configured to determine chest compression feedback that varies based on the user input and is based at least in part on the motion of the chest during the administration of chest compressions, and a display configured to display the chest compression feedback.

Abstract: A cardiopulmonary resuscitation system capable of performing passive oxygen administration with reduced oxygen consumption as compared with a conventional passive oxygen administration method. A cardiopulmonary resuscitation system which includes: a sternum compression unit that repeats a sternum compression cycle having, as one cycle, a compression period and a recoil period; an artificial respiration unit that repeats an artificial respiration cycle having, as one cycle, an inhalation period and an exhalation period and can supply oxygen administering gas to a patient during the recoil period; and a control means (not illustrated) that controls the artificial respiration unit and/or the sternum compression unit, and the controller judges, for each recoil period, whether supply of oxygen administering gas is required and sends a supply instruction signal to administer oxygen administering gas to the artificial respiration means unless it is judged that supply of the oxygen administering gas is not required.

Abstract: A bath system comprises a tub and a fluid injection system. The tub has a jet orifice, and the fluid injection system is fluidly coupled to the jet orifice. The fluid injection system comprises a conduit, a heat source, an air supply source, and a fluid injector. The conduit has a central opening. The heat source is coupled to an outer portion of the conduit external to the central opening. The air supply source is fluidly coupled to the conduit, and is configured to provide a flow of air to the central opening. The fluid injector is configured to provide an atomized spray of water to the flow of air to produce a combined flow of air and water. The heat source and the conduit are cooperatively configured to heat the combined flow of air and water in the central opening before the combined flow enters the tub through the jet orifice.

Abstract: The present invention relates to a method for controlling an acupressure force and a body scan in real-time and, more specifically, the method comprises the steps of: (a) setting a reference vertical height for each horizontal position of an acupressure part, and setting a target acupressure force within the range of the reference vertical height; (b) calculating a current measurement acupressure force by means of a user's load measurement data applied to a load cell; and (c) comparing the target acupressure force with the current measurement acupressure force so as to control the vertical height of the acupressure part.

Abstract: An adapter for connection with a fluid container includes an outer housing having a distal end, a proximal end, and a substantially cylindrical sidewall extending between the distal end and the proximal end, an inner member including a body rotatably inserted within the outer housing, a connector extending from the body configured to connect the adapter to a fluid container, and at least one grasping member extending from the inner member, the grasping member being configured for grasping by a user of the adapter, a first locking arrangement engageable with a distal end of the inner member and configured to restrict the inner member from rotating relative to the outer housing in a first direction, and a second locking arrangement engageable with a proximal end of the inner member and configured to restrict the inner member from moving in a proximal direction relative to the outer housing.

Abstract: Techniques are disclosed for providing a drug-dispensing device that tracks temperatures to which a drug stored therein is exposed, further providing means for indicating to a user that the drug has been exposed to temperatures outside a suitable temperature range and/or preventing the drug from being dispensed in such cases. According to some embodiments, an electrochromic element may be used to indicate the drug has been exposed to temperatures outside the suitable temperature range.

Abstract: To realize creation of a state in which two types of substances are communicated to each other via the double-ended needle assembly by a one-step continuous push operation and reduce a probability of entry of air or liquid leakage at that time. A syringe device 1 includes an administration holder 2, and a cylinder portion 6 which allows insertion of the administration holder 2. The cylinder portion 6 includes a coupling holder 3, a slit holder 4 coupled to the coupling holder 3, and a double-ended needle assembly 5 disposed slidably in an interior of the coupling holder 3. A cartridge for a freeze-dry product is mounted in the administration holder 2, and a cartridge for solvent is mounted in the coupling holder 3. When the administration holder 2 is pushed, the double-ended needle assembly 5 slides.

Abstract: A tablet has a first layer printed using visible ink and a second layer printed using invisible ink. The first layer includes characters, a trademark, or the like printed using the visible ink, which can be visually confirmed by an administrator in charge or a tablet user. The second layer includes a barcode or the like printed using the invisible ink, which cannot be visually confirmed by the administrator or the tablet user. The second layer is visualized by black light or the like so as to be made readable. The tablet is subjected to print processing by a tablet printing device provided with conveying disks A to C conveying the tablet while sucking and supporting a side surface of the tablet. The first layer 51 and the second layer are printed by inkjet heads, respectively.

Abstract: A tablet cassette is provided that can easily adjust the width of a guide groove of a rotor depending on the size of a tablet to be dispensed. The tablet cassette includes a groove width adjustment mechanism that relatively moves both sides of each of the tablet guide grooves in a circumferential direction of the rotor.

Abstract: Disclosed are hypodermic needle devices having an easily-observed, visual indication that the drug contents of the device have expired. The visual indication may be triggered when a counter maintained by a processor of the hypodermic needle device has exceeded a time threshold. The time threshold may be configured based on the drug threshold, and the counter and time threshold may be manually or dynamically adjusted as real-world conditions change to alter the time to expiration. For instance, an prolonged increase in temperature detected by the temperature sensor may speed up the expiration rate of the drug and require a reduction in the time threshold.

Abstract: The present invention relates to an intelligent medication dispensing device that gives a patient access to his/her right daily doses of oral solid medications anywhere at the right time. The device is programmed to alert the patient when the doses due time occurs. The medication dispensing device of the present invention comprises essentially a plurality of cartridges divided into a plurality of compartments, a plurality of cylinders to position the cartridges in the device of the present invention, a medication box, a non-taken medication storage component, a portable component, and a plurality of actuators. The portable component can be taken by the patient to any place in order for such patient to adhere to his/her medication doses. The device of the present invention stores the missed dosages in the non-taken medication storage component, and thus prevents the accumulation of such missed doses with a new dose, which has its due time occurred.

Abstract: Exemplary embodiments of the disclosure may be drawn to a device having a vessel configured to contain a source of lipids and a chamber fluidly connected to an outlet of the vessel. The chamber may contain immobilized lipase positioned within a flow path in the chamber along which the lipids flow when released from the vessel into the chamber. The device may also include an outlet through which the lipids flow after passing through the chamber.

Abstract: Described are a method for producing cellulose fibers suitable for use in a thickening composition, a method for producing a thickening composition that contains the cellulose fibers, and a method for thickening a composition. The method for producing the cellulose fibers includes grinding a composition containing cellulose fibers and an aqueous solution to produce a dispersion containing cellulose fibers having an average fiber diameter (D) in a range of from 0.001 to 100 ?m in the aqueous solution.

Abstract: The present invention provides a water-in-oil polymeric emulsion composition, including: (a) 25 to 65 wt % of a cross-linked polymer, (b) 15 to 40 wt % of an oil; (c) 1 to 12 wt % of a surfactant; and (d) 1 to 40 wt % of water, wherein (a) the cross-linked polymer is polymerized by using 35 to 85 mol % of a 2-arylamido-2-methylpropane-sulfonic acid totally or partially salified by an alkali metal or ammonium, 15 to 65 mol % of acryloyl morpholine, and 0.005 to 1 mol % of a polyethylenic monomer used as a cross-linking agent.

Abstract: Silica-including microcapsule resin particles including an outer shell constituted of a crosslinked polymer and a cavity partitioned with the outer shell, in which the silica-including microcapsule resin particles contain inside the cavity a porous structure in which silica particles are mutually connected, and have a volume average particle diameter of 0.5 to 100 ?m.

Abstract: Sunscreen compositions comprising a dermatologically acceptable carrier and a polyhydroxy fullerene compound are described. The sunscreen compositions can be used to protect a substrate such as the skin of a subject from the effects of ultraviolet radiation.

Abstract: Methods for preparing high loading core shell silica (CSS) particles, or CSS particles having a relatively greater amount of surface active silicate groups than CSS particles prepared according to conventional methods is provided. The method may include contacting silica particles with a base having a first metal ion to produce core shell silica particles. Each of the core shell silica particles may include a silica core and a silicate of the first metal ion etched on a surface of the silica core. The method may also include contacting each of the core shell silica particles having the silicate of the first metal ion with an acidic aqueous solution including a metal salt having a second metal ion to produce core shell silica particles including the silica core and a silicate of the second metal ion on the surface of the silica core.

Abstract: A personal wash composition which provides an effective antimicrobial benefit against fungi, gram positive and gram negative bacteria, which composition comprises: a) from 0.1% to 10 wt % betaine surfactant, b) from 0.1% to 5.0 wt % lactic acid, c) from 0.1% to 20 wt % polyhydric C2-C6 alcohol, d) from 0% to 10 wt % alkyl polyethoxy carboxylate of the formula RO(CH2CH2O)kCH2COO?M+ wherein R is a C8-C22 alkyl, k is an integer from 0 to 20, and M is a soluble salt-forming cation, e) from 0% to 10 wt % alkyl polyethoxy amides of the formula RO(CH2CH2O)kCH2CONH2 wherein R is a C8-C22 alkyl, k is an integer from 0 to 20, f) >8 wt % alkyl ether sulphate, g) water, h) a pH of 3.8-4.5, i) 10-20 wt % total surfactant, j) from 0.1 to 10 wt % metal salt.

Abstract: To provide an inhibitor of melanin decomposition, which inhibits decomposition of melanin in keratinocytes to accelerate accumulation of melanin in skin and hair. An inhibitor of melanin decomposition in keratinocytes, comprising at least one selected from the group consisting of a plant extract containing berberine or a salt thereof, berberine or a salt thereof, proguanil or a salt thereof and phenformin or a salt thereof, as an active ingredient.

Abstract: The invention relates to the discovery that collagenase injections are effective in dissolving and lysing the collagenase septa network in the skin that comprises cellulite. As such, the invention relates to methods of treating cellulite in a patient in need of such treatment comprising injecting or otherwise delivering the effective amount of purified collagenase to the collagenase septa network of cellulite in the skin. The invention also relates to the use of collagenase in the manufacture of a medicament to treat cellulite of the skin.

Abstract: Disclosed is an anhydrous lip moisturizing composition and a method of use for moisturizing lips. The composition can include 20% to 30% by weight of caprylic/capric triglyceride; 12% to 22% by weight of tridecyl trimellitate; 1% to 15% by weight of jojoba esters; 5% to 10% by weight of Helianthus annus (sunflower) seed oil; 2% to 10% by weight of microcrystalline wax; and 2% to 10% by weight of beeswax.

Abstract: The present disclosure relates to a skin care cosmetic set. The skin care cosmetic set comprises a facial cleanser, a skin care toner, a serum, a whitening cream and a protective emulsion. The facial cleanser comprises an olive extract and a wheat extract; the skin care toner comprises sodium hyaluronate, a hamamelis virginiana extract and betaine; the serum comprises an aloe extract, a soybean extract, EGF moisturizing factors and sodium hyaluronate; the whitening cream comprises cetyl alcohol, vaseline, vitamin E and sodium hyaluronate; the protective emulsion comprises a wheat extract, glycerol, alpha-bisabolol and nano-titanium dioxide, and also discloses an application method thereof. The present invention is used by combinations to form a multi-layer skin care layer, and each skin care layer cooperate with each other, so that the skin care has more comprehensive effect.

Abstract: Compositions for nail varnish, which are free or substantially free of nitrocellulose, include, in a cosmetically acceptable organic solvent: a primary film-forming agent consisting of polyvinyl butyral, a fumed silica, at least one secondary resin, at least one plasticiser, at least one colourant, which is insoluble in said solvent. The disclosure also relates to the use of the compositions for protecting and/or making-up the nails, as well as to packaged, ready-to-use items intended for the use.

Abstract: A cosmetic composition is disclosed, which comprises: (A) 100 parts by weight of at least one vinyl polymer having at least one carbosiloxane dendrimer group in a side chain; (B) from 0.1 to 30 parts by weight of a surfactant; and (X) water; wherein an emulsified particle comprising at least component (A) and component (B) is in an aqueous phase; and wherein a weight average molecular weight of component (A) is at least 80000. By blending a vinyl polymer emulsion having a carbosiloxane dendrimer structure in an aqueous phase according to the present invention, a cosmetic that exhibits excellent softness, texture during usage and smoothness of finish, waterproofness, and makeup retaining properties can be provided.

Abstract: An actinic light curable dip gel comprises an acrylic resin selected from the group consisting of a poly(C1-12alkyl(meth)acrylate) polymer, an acrylate functional acrylic resin, and mixtures thereof; a monomer; at least one photoinitiator; and a solvent. A layer of this actinic light curable dip gel is applied onto a nail, followed by an application of a polymer powder onto the nail; and exposing the nail to actinic light. The steps of applying the gel layer and the polymer powder may be repeated several times prior to exposing the nail to actinic light. The use of the actinic light curable dip gel has several advantages over the traditional dip system.

Abstract: The present invention relates to a cosmetic composition for the temporary shaping of hair, which includes a combination of two specific anionic acrylate resins. The cosmetic composition provides a very good combination of stiffness and long-lasting hold.

Abstract: The present invention provides a water-in-oil polymeric emulsion composition, including: (a) 25 to 65 wt % of a cross-linked polymer; (b) 15 to 40 wt % of an oil; (c) 1 to 12 wt % of a surfactant; and (d) 1 to 40 wt % of water, wherein (a) the cross-linked polymer is polymerized by using 35 to 85 mol % of a 2-acrylamido-2-methylpropane-sulfonic acid totally or partially salified by an alkali metal or ammonium, 10 to 50 mol % of acryloyl morpholine, 2 to 25 mol % of an acrylic acid totally or partially salified by an alkali metal or ammonium, and 0.005 to 1 mol % of a polyethylenic monomer used as a cross-linking agent.

Abstract: Described herein are whitening compositions comprising a substantially anhydrous or non-aqueous oral care composition comprising: a peroxide source comprising hydrogen peroxide bound to cross-linked polyvinylpyrrolidone (cPVP) in the amount effective to provide from 0.01% to 5.5% of hydrogen peroxide, by weight of the composition; a hydrophobic component comprising a silicone polymer; sodium tripolyphosphate; and optionally a dental surface adhesion enhancing agent. Methods of making and using these compositions are also described herein.

Abstract: The present invention relates to a silicone fluid comprising a glycoside group and oil in water emulsions composition of silicone fluid used in hair care compositions for hair care applications, process for their preparations and their uses. The current invention is to provide an oil-in-water emulsion used as a shampoo additive composition that will help hair care application for shine as well as easy manageability and alignment along with conditioning benefits. The emulsion having a D50 particle size less than 3 micrometers comprising a silicone fluid, a mixture of non-ionic emulsifier; and water, wherein, the silicone fluid is of viscosity of at least 4500 mPa·s at 25° C.

Abstract: Pure oil-based personal care products containing less than or equal to 1 wt. % of water, contain alkyl glycoside modified polysiloxanes of Formula (I) where x, y and z are between 1 and 10,000, n and m are between 1 and 20, alkyl is a linear or branched C2-C20 hydrocarbon, and W is a linear or branched C2-C20 alkylene.

Abstract: An oil-based eyelash cosmetic including 22 to 50% by mass of a wax (A) containing a wax having a melting point of 50° C. to less than 70° C. (A-1) and a wax having a melting point of 70° C. to 110° C. (A-2), 0.1 to 10% by mass of a nonionic surfactant having an HLB value of 6 to 12 (B), 20 to 70% by mass of a volatile oil (C) and 0 to 5% by mass of water (E), and having the ratio by mass of the component (A-1) to the component (A-2) [(A-1)/(A-2) ] of 1/0.2 to 1/5, is excellent in removability by warm water as well as volume effect, curling effect and long-lasting performance of cosmetic effect such as water resistance. Hence, makeup using the oil-based eyelash cosmetic can be removed by washing with warm water without using a special remover.

Abstract: The present disclosure provides compositions and methods for treating dermatological disorders using a formulation comprising Typhonium giganteum extract.

Abstract: The present invention provides methods, compositions and kits for extracting botanical compounds from plant parts using a carrier medium comprising a bio-based farnesene, a hydrocarbon composition derived from the bio-based farnesene or a combination thereof. In certain embodiments, rose petals are used as a plant material, and a squalane composition derived from bio-based farnesene is used as a carrier medium.

Abstract: A modified release formulation of lacosamide suitable for once-daily administration.

Abstract: Compositions containing tiotropium or a pharmaceutically acceptable salt or solvate thereof, citric acid or a salt thereof, glycerol, ethanol, and a propellant, as well as aerosol canisters and inhalers containing the same. Methods of manufacturing and using the compositions, aerosol canisters, and inhalers.

Abstract: The present invention relates to compositions and in particular to compositions for treating a skin or mucosal membrane infection.

Abstract: Provided herein are polymer-stabilized CaP nanoparticle formulations and related methods of manufacture. In certain embodiments, the methods reliably and selectively form nanoparticles with homogenous size, charge, and morphology. The CaP nanoparticles include calcium ions and phosphate ions with an ionic polymer, thereby forming stable hybrid nanoparticles. The CaP nanoparticle formulations include powders, suspensions and injectable pastes. According to various embodiments, the polymer-stabilized CaP nanoparticles may be polycation-stabilized (CaP/polymer(+) nanoparticles) or polyanion-stabilized (CaP/polymer(-) nanoparticles). The CaP/polymer nanoparticles can be freeze-dried and stored for months with no loss of properties or changes to their morphology.

Abstract: A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a patient who has experienced a first clinical episode and is determined to be at high risk of developing clinically definite multiple sclerosis comprising administering to the human patient three subcutaneous injections of a therapeutically effective dose of glatiramer acetate over a period of seven days with at least one day between every subcutaneous injection so as to thereby alleviate the symptom of the patient.

Abstract: Described herein is a method of transdermally administering one or more pharmaceutically active agents to a mammal. The method comprises administering one or more active pharmaceutical agents to the skin of the subject, in conjunction with microneedles and one or more COX inhibitors, whereby the COX inhibitors facilitate the absorption of the active pharmaceutical agents by prolonging the pore opening created by the application of the microneedle.

Abstract: The present invention provides a temperature sensitive hydrogel composition including a nucleic acid and chitosan. Since the hydrogel has excellent biocompatibility and biostability, and simultaneously has sol-gel phase transition properties depending on temperature changes, the hydrogel is present in a sol state at room temperature and becomes a gel when the hydrogel is injected into the human body or applied on the surface of epithelial skin and the temperature increases. Thus, the temperature-sensitive hydrogel of the present invention can be directly injected into and applied on certain parts requiring treatment and the retention and attaching time of a drug is increased through gelation depending on the temperature so that drug efficacy is sufficiently exhibited. Therefore, it is expected that the temperature-sensitive hydrogel of the present invention can be utilized for various treatments.